References
- Ishida J, Kozuka M, Wang H, Konoshima T, Tokuda H, Okuda M, Yang Mou X, Nishino H, Sakurai N, Lee KH, Nagai M. (2000). Antitumor-promoting effects of cyclic diarylheptanoids on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis. Cancer Lett, 159, 135–140.
- Ishida J, Kozuka M, Tokuda H, Nishino H, Nagumo S, Lee KH, Nagai M. (2002). Chemopreventive potential of cyclic diarylheptanoids. Bioorg Med Chem, 10, 3361–3365.
- Ito Y, Yanase S, Fujita J, Harayama T, Takashima M, Imanaka H. (1981). A short-term in vitro assay for promoter substances using human lymphoblastoid cells latently infected with Epstein-Barr virus. Cancer Lett, 13, 29–37.
- Itoigawa M, Ito C, Ju-ichi M, Nobukuni T, Ichiishi E, Tokuda H, Nishino H, Furukawa H. (2002). Cancer chemopreventive activity of flavanones on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis. Cancer Lett, 176, 25–29.
- Iwase Y, Takemura Y, Ju-ichi M, Ito C, Furukawa H, Kawaii S, Yano M, Mou XY, Takayasu J, Tokuda H, Nishino H. (2000). Inhibitory effect of flavonoids from citrus plants on Epstein-Barr virus activation and two-stage carcinogenesis of skin tumors. Cancer Lett, 154, 101–105.
- Jin J, Sun H, Wei H, Liu G. (2007). The anti-hepatitis drug DDB chemosensitizes multidrug resistant cancer cells in vitro and in vivo by inhibiting P-gp and enhancing apoptosis. Invest New Drugs, 25, 95–105.
- Konoshima T, Takasaki M, Tatsumoto T, Kozuka M, Kasai R, Tanaka O, Nie RL, Tokuda H, Nishino H, Iwashima A. (1994). Inhibitory effects of cucurbitane triterpenoids on Epstein-Barr virus activation and two-stage carcinogenesis of skin tumors. Biol Pharm Bull, 17, 668–671.
- Nakagawa-Goto K, Yamada K, Taniguchi M, Tokuda H, Lee KH. (2009). Cancer preventive agents 9. Betulinic acid derivatives as potent cancer chemopreventive agents. Bioorg Med Chem Lett, 19, 3378–3381.
- Nishino H, Tokuda H, Satomi Y, Masuda M, Onozuka M, Yamaguchi S, Takayasu J, Tsuruta J, Takemura M, Ii T, Ichiishi E, Kuchide S, Okuda M, Murakoshi M. (2000). Cancer Chemoprevention by Phytochemicals and their Related Compounds. Asian Pac J Cancer Prev, 1, 49–55.
- Sakurai N, Kozuka M, Tokuda H, Nobukuni Y, Takayasu J, Nishino H, Kusano A, Kusano G, Nagai M, Sakurai Y, Lee KH. (2003). Antitumor agents 220. Antitumor-promoting effects of cimigenol and related compounds on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis. Bioorg Med Chem, 11, 1137–1140.
- Sun H, Liu GT. (2005). Chemopreventive effect of dimethyl dicarboxylate biphenyl on malignant transformation of WB-F344 rat liver epithelial cells. Acta Pharmacol Sin, 26, 1339–1344.
- Tatsuzaki J, Nakagawa-Goto K, Tokuda H, Lee KH. (2010). Cancer preventive agents 10. Prenylated dehydrozingerone analogs as potent chemopreventive agents. J Asian Nat Prod Res, 12, 227–232.
- Wang X, Nakagawa-Goto K, Kozuka M, Tokuda H, Nishino H, Lee KH. (2006). Cancer preventive agents. Part 6: Chemopreventive potential of furanocoumarins and related compounds. Pharmaceut Biol, 44, 116–120.
- Xie L, Xie JX, Kashiwada Y, Cosentino LM, Liu SH, Pai RB, Cheng YC, Lee KH. (1995). Anti-AIDS (acquired immune deficiency syndrome) agents. 17. New brominated hexahydroxybiphenyl derivatives as potent anti-HIV agents. J Med Chem, 38, 3003–3008.